Study details
Enrolling now
Valacyclovir for Acute Apical Abscess Pain
University of California, San Francisco
NCT IDNCT05266040ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
60
Study length
about 2.2 years
Ages
18–80
Locations
1 site in CA
What this study is about
Researchers are testing whether valacyclovir helps with pain from acute apical abscesses. The trial will involve 60 adults and last about 798 days. It's looking at how well valacyclovir works compared to a placebo.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take Valacyclovir 500 MG
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
valaciclovir (Antiviral; prodrug of acyclovir)
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Measurement of pain levels following treatment intervention